Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Arnaboldi

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Atherosclerosis. Supplements|January 11, 2015
Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatinLorenzo Arnaboldi, Alberto Corsini
Current Opinion in Lipidology|June 29, 2010
Do structural differences in statins correlate with clinical efficacy?Lorenzo Arnaboldi, Alberto Corsini
Minerva Medica|March 22, 2022
Artichoke and bergamot extracts: a new opportunity for the management of dyslipidemia and related risk factorsLorenzo Arnaboldi, Alberto Corsini, Stefano Bellosta
Expert Opinion on Drug Safety|February 20, 2020
Treatment of dyslipidemia in kidney transplantationClaudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2024
How We Treat Dyslipidemia in Prolonged Nephrotic SyndromeClaudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9Lorenzo Arnaboldi, Zixiong Tang, Nicola Ferri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2011
Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiationPaola Ciceri, Elisa Volpi, Irene Brenna, et al.
American Journal of Physiology. Renal Physiology|August 20, 2010
Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotectionCarla Zoja, Daniela Corna, Elena Gagliardini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 17, 2004
Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100Christofer Flood, Maria Gustafsson, Robert E Pitas, et al.
Pharmacological Research|October 26, 2007
Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferationLorenzo Arnaboldi, Massimiliano Guzzetta, Franco Pazzucconi, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Atherosclerosis. Supplements|January 11, 2015
Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatinLorenzo Arnaboldi, Alberto Corsini
Current Opinion in Lipidology|June 29, 2010
Do structural differences in statins correlate with clinical efficacy?Lorenzo Arnaboldi, Alberto Corsini
Minerva Medica|March 22, 2022
Artichoke and bergamot extracts: a new opportunity for the management of dyslipidemia and related risk factorsLorenzo Arnaboldi, Alberto Corsini, Stefano Bellosta
Expert Opinion on Drug Safety|February 20, 2020
Treatment of dyslipidemia in kidney transplantationClaudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2024
How We Treat Dyslipidemia in Prolonged Nephrotic SyndromeClaudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9Lorenzo Arnaboldi, Zixiong Tang, Nicola Ferri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2011
Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastic differentiationPaola Ciceri, Elisa Volpi, Irene Brenna, et al.
American Journal of Physiology. Renal Physiology|August 20, 2010
Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotectionCarla Zoja, Daniela Corna, Elena Gagliardini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 17, 2004
Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100Christofer Flood, Maria Gustafsson, Robert E Pitas, et al.
Pharmacological Research|October 26, 2007
Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferationLorenzo Arnaboldi, Massimiliano Guzzetta, Franco Pazzucconi, et al.
Pageof 3